Found: 21
Select item for more details and to access through your institution.
Safety and Immunogenicity of Bivalent RSVpreF Vaccine Coadministered With Seasonal Inactivated Influenza Vaccine in Older Adults.
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 5, p. 1360, doi. 10.1093/cid/ciad707
- By:
- Publication type:
- Article
Epidemiology of Invasive Escherichia coli Infection and Antibiotic Resistance Status Among Patients Treated in US Hospitals: 2009–2016.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 4, p. 565, doi. 10.1093/cid/ciab005
- By:
- Publication type:
- Article
Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F Vaccine With and Without Adjuvant in Healthy Older Adults.
- Published in:
- Journal of Infectious Diseases, 2022, v. 226, n. 12, p. 2054, doi. 10.1093/infdis/jiac189
- By:
- Publication type:
- Article
Phase 1/2 Randomized Study of the Immunogenicity, Safety, and Tolerability of a Respiratory Syncytial Virus Prefusion F Vaccine in Adults With Concomitant Inactivated Influenza Vaccine.
- Published in:
- Journal of Infectious Diseases, 2022, v. 225, n. 12, p. 2056, doi. 10.1093/infdis/jiab611
- By:
- Publication type:
- Article
Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F Vaccine When Coadministered With a Tetanus, Diphtheria, and Acellular Pertussis Vaccine.
- Published in:
- Journal of Infectious Diseases, 2022, v. 225, n. 12, p. 2077, doi. 10.1093/infdis/jiab505
- By:
- Publication type:
- Article
A Randomized Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F Vaccine.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Immunogenicity of the Monovalent Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine against XBB.1.5, BA.2.86, and JN.1 Sublineages: A Phase 2/3 Trial.
- Published in:
- Vaccines, 2024, v. 12, n. 7, p. 734, doi. 10.3390/vaccines12070734
- By:
- Publication type:
- Article
Safety and Immunogenicity of the Monovalent Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine in Individuals ≥12 Years Old: A Phase 2/3 Trial.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 118, doi. 10.3390/vaccines12020118
- By:
- Publication type:
- Article
Multicenter Surveillance of Streptococcus pneumoniae Isolates From Middle Ear and Mastoid Cultures in the 13-Valent Pneumococcal Conjugate Vaccine Era.
- Published in:
- Clinical Infectious Diseases, 2015, v. 60, n. 9, p. 1339, doi. 10.1093/cid/civ067
- By:
- Publication type:
- Article
Comparative Immunogenicity and Efficacy of 13-Valent and 7-Valent Pneumococcal Conjugate Vaccines in Reducing Nasopharyngeal Colonization: A Randomized Double-Blind Trial.
- Published in:
- Clinical Infectious Diseases, 2013, v. 57, n. 7, p. 952, doi. 10.1093/cid/cit428
- By:
- Publication type:
- Article
Persistence of Immune Responses Through 36 Months in Healthy Adults After Vaccination With a Novel Staphylococcus aureus 4-Antigen Vaccine (SA4Ag).
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 1, p. N.PAG, doi. 10.1093/ofid/ofz532
- By:
- Publication type:
- Article
Depressive Symptoms and AIDS-Related Mortality Among a Multisite Cohort of HIV-Positive Women.
- Published in:
- American Journal of Public Health, 2004, v. 94, n. 7, p. 1133, doi. 10.2105/AJPH.94.7.1133
- By:
- Publication type:
- Article
Pseudomonas aeruginosa Bacteremia in Patients with AIDS.
- Published in:
- Clinical Infectious Diseases, 1994, v. 18, n. 6, p. 886
- By:
- Publication type:
- Article
Correction: Neutrophil killing of Staphylococcus aureus in diabetes, obesity and metabolic syndrome: a prospective cellular surveillance study.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
13-valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6-17 years of age with sickle cell disease previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study.
- Published in:
- Pediatric Blood & Cancer, 2015, v. 62, n. 8, p. 1427, doi. 10.1002/pbc.25502
- By:
- Publication type:
- Article
Neutrophil killing of Staphylococcus aureus in diabetes, obesity and metabolic syndrome: a prospective cellular surveillance study.
- Published in:
- Diabetology & Metabolic Syndrome, 2017, v. 9, p. 1, doi. 10.1186/s13098-017-0276-3
- By:
- Publication type:
- Article
Immunogenicity and Safety of a Third COVID-19 BNT162b2 mRNA Vaccine Dose in 5- to 11-Year Olds.
- Published in:
- Journal of the Pediatric Infectious Diseases Society, 2023, v. 12, n. 4, p. 234, doi. 10.1093/jpids/piad015
- By:
- Publication type:
- Article
JC virus granule cell neuronopathy: A novel clinical syndrome distinct from progressive multifocal leukoencephalopathy.
- Published in:
- Annals of Neurology, 2005, v. 57, n. 4, p. 576
- By:
- Publication type:
- Article
The incidence of stroke among selected patients undergoing elective posterior lumbar fusion: a retrospective cohort study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in HIVInfected Adults Previously Vaccinated With Pneumococcal Polysaccharide Vaccine.
- Published in:
- Journal of Infectious Diseases, 2015, v. 212, n. 1, p. 18, doi. 10.1093/infdis/jiu631
- By:
- Publication type:
- Article
Efficacy of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus That of 7-Valent PCV (PCV7) Against Nasopharyngeal Colonization of Antibiotic-Nonsusceptible Streptococcus pneumoniae.
- Published in:
- Journal of Infectious Diseases, 2015, v. 211, n. 7, p. 1144, doi. 10.1093/infdis/jiu576
- By:
- Publication type:
- Article